J. Hertel

发表

Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4

M. Blaney, J. Wetmore, M. Oliver, 2010, Journal of Thrombosis and Thrombolysis.

Safety of ferumoxytol in patients with anemia and CKD.

Ajay K. Singh, A. Kausz, J. Hertel, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.

I. Macdougall, W. Strauss, J. Hertel, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Darbepoetin alfa Administered Every Other Week Maintains Hemoglobin Levels over 52 Weeks in Patients with Chronic Kidney Disease Converting from Once-Weekly Recombinant Human Erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)

D. Scarlata, P. Audhya, J. Hertel, 2006, American Journal of Nephrology.

Assessment of time and practice resources required to provide weekly or monthly erythropoiesis-stimulating protein therapy to chronic kidney disease patients in the physician office setting.

T. Goss, D. Globe, P. Crawford, 2006, Journal of managed care pharmacy : JMCP.

Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease.

D. Scarlata, P. Audhya, J. Hertel, 2006, Mayo Clinic proceedings.

Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia

C. Wanner, F. Locatelli, G. Spasovski, 2015, Nephron.

Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with CKD and their families.

T. Goss, D. Globe, R. Kewalramani, 2007, Nephrology nursing journal : journal of the American Nephrology Nurses' Association.

Permeability and secondary membrane formation of a high flux polysulfone hemofilter.

J. Hertel, N. Panitz, D. Walb, 1986, Kidney international.

Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol.

A. R. González, M. Plone, J. Hertel, 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Eosinophilia and cellular cytokine responsiveness in hemodialysis patients.

P. Kimmel, J. Bosch, T. Phillips, 1992, Journal of the American Society of Nephrology : JASN.

ETHYLENE OXIDE HYPERSENSITIVITY IN DIALYSIS PATIENTS

U. Wahn, J. Hertel, P. Fiegel, 1986, The Lancet.

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

S. Hemmerich, A. Besarab, R. Leong, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Allergy to dialysis materials.

X. Baur, J. Hertel, D. Walb, 1989, Nephrology, Dialysis and Transplantation.

Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption.

J. Hertel, N. Panitz, D. Walb, 1987, Nephrology, Dialysis and Transplantation.

Clinical Relevance of the Ethylene-Oxide-RAST in Patients on RDT

J. Hertel, N. Panitz, D. Walb, 1986 .